English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18076/20274 (89%)
造訪人次 : 5356653      線上人數 : 1325
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34518


    標題: Optimal Lymph Node Yield for Survival Prediction in Rectal Cancer Patients After Neoadjuvant Therapy
    作者: Lin, Yu-Min
    Chou, Chia-Lin
    Kuo, Yu-Hsuan
    Wu, Hung-Chang
    Tsai, Chia-Jen
    Ho, Chung-Han
    Chen, Yi-Chen
    Yang, Ching-Chieh
    Lin, Cheng-Wei
    貢獻者: Chi Mei Med Ctr, Dept Internal Med, Div Hepatogastroenterol
    Chi Mei Med Ctr, Dept Surg, Div Colorectal Surg
    Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol
    Chi Mei Med Ctr, Dept Internal Med, Div Hematol & Oncol
    Chia Nan Univ Pharm & Sci, Dept Cosmet Sci
    Chia Nan Univ Pharm & Sci, Dept Pharm
    Chi Mei Med Ctr, Dept Radiat Oncol
    Chi Mei Med Ctr, Dept Med Res
    Southern Taiwan Univ Sci & Technol, Dept Informat Management
    Taipei Med Univ, Coll Med, Sch Med, Dept Biochem & Mol Cell Biol
    Taipei Med Univ, Coll Med, Grad Inst Med Sci
    Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr
    關鍵字: rectal cancer
    neoadjuvant therapy
    lymph node yield
    quality
    survival
    日期: 2021
    上傳時間: 2023-11-11 12:00:34 (UTC+8)
    出版者: DOVE MEDICAL PRESS LTD
    摘要: Purpose: A lymph node (LN) yield >12 is required to for accurate determination of nodal status for colorectal cancer but cannot always be achieved after neoadjuvant therapy. This study aims to determine the difference in LN yield from rectal cancer patients treated with and without neoadjuvant therapy and the effects of specific LN yields on survival. Patients and Methods: The study cohort included a total of 4344 rectal cancer patients treated between January 2007 and December 2015, 2260 (52.03%) of whom received neoadjuvant therapy. Data were retrieved from the Taiwan nationwide cancer registry database. The minimum acceptable LN yield below 12 was investigated using the maximum area under the ROC curve. Results: The median LN yield was 12 (8-17) for patients who received neoadjuvant therapy and 17 (13-24) for those who did not. The recommended LN yield >12 was achieved in 82.73% of patients without and 57.96% of those with neoadjuvant therapy (p < 0.0001). Patients with LN yield >12 had a higher OS probability than did those with LN <12 (OR, 1.33; 95% CI, 1.06-1.66; p = 0.0124). However, the predictive accuracy for survival was greater for LN yield >10 (AUC, 0.7767) than cut-offs of 12, 8, or 6, especially in patients with pathologically-negative nodes (AUC, 0.7660). Conclusion: Neoadjuvant therapy significantly reduces the LN yield in subsequent surgery. A lower yield (LN > 10) may be adequate for nodal evaluation in rectal cancer patients after neoadjuvant therapy.
    關聯: CANCER MANAG RES, v.13, pp.8037-8047
    顯示於類別:[化妝品應用與管理系(所)] 期刊論文
    [藥學系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    CMAR.S328666.pdf3825KbAdobe PDF119檢視/開啟
    index.html0KbHTML194檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋